Relative bioavailability and safety profile of gefitinib administered as a tablet or as a dispersion preparation via drink or nasogastric tube: results of a randomized, open-label, three-period crossover study in healthy volunteers
2004 ◽
Vol 26
(10)
◽
pp. 1630-1636
◽
Keyword(s):
2012 ◽
Vol 34
(7)
◽
pp. 1601-1612
◽
2011 ◽
Vol 27
(11)
◽
pp. 2203-2211
◽
Keyword(s):
2004 ◽
Vol 26
(12)
◽
pp. 2092-2101
◽
2010 ◽
Vol 32
(13)
◽
pp. 2258-2264
◽
Keyword(s):
2012 ◽
Vol 52
(8)
◽
pp. 1255-1264
◽
Keyword(s):
2010 ◽
Vol 32
(2)
◽
pp. 338-346
◽
Keyword(s):
2013 ◽
Vol 51
(02)
◽
pp. 152-160
◽
2017 ◽
Vol 57
(10)
◽
pp. 1305-1314
◽
2007 ◽
Vol 29
(5)
◽
pp. 900-908
◽
Keyword(s):
2006 ◽
Vol 28
(1)
◽
pp. 45-54
◽